A 1 PHE 30 -10.348 -12.608
A 2 LYS 3 -13.765 -12.527
A 3 VAL 28 -17.546 -18.748
A 4 ALA 10 -19.771 -18.648
A 5 THR 23 -20.754 -21.012
A 6 PRO 15 -19.072 -18.603
A 7 TYR 16 -20.182 -19.701
A 8 SER 8 -21.185 -19.669
A 9 LEU 6 -19.861 -18.267
A 10 TYR 34 -20.118 -21.714
A 11 VAL 9 -16.549 -15.681
A 12 CYS 28 -15.023 -16.515
A 13 PRO 10 -9.757 -9.785
A 14 GLU 8 -7.946 -7.952
A 15 GLY 5 -7.840 -7.513
A 16 GLN 21 -11.156 -12.288
A 17 ASN 11 -13.222 -12.966
A 18 VAL 34 -17.303 -19.223
A 19 THR 12 -19.945 -19.031
A 20 LEU 37 -22.226 -23.925
A 21 THR 15 -22.001 -21.196
A 22 CYS 29 -21.848 -22.671
A 23 ARG 8 -19.353 -18.047
A 24 LEU 27 -15.214 -16.570
A 25 LEU 7 -12.848 -12.176
A 26 GLY 11 -8.602 -8.878
A 27 HIS 22 -7.217 -8.917
A 28 ASP 0 -3.546 -3.138 <=B
A 29 VAL 17 -4.778 -6.183
A 30 THR 6 -6.293 -6.260
A 31 PHE 30 -10.584 -12.817
A 32 TYR 13 -11.751 -11.895
A 33 LYS 28 -14.619 -16.158
A 34 THR 24 -15.921 -16.850
A 35 TRP 33 -20.830 -22.229
A 36 TYR 21 -20.124 -20.225
A 37 ARG 18 -18.776 -18.687
A 38 SER 23 -18.115 -18.676
A 39 SER 6 -13.931 -13.019
A 40 ARG 10 -14.319 -13.822
A 41 GLY 3 -8.664 -8.013
A 42 GLU 15 -9.317 -9.971
A 43 VAL 0 -6.465 -5.722
A 44 GLN 7 -9.749 -9.433
A 45 THR 15 -16.324 -16.172
A 46 CYS 19 -19.432 -19.383
A 47 SER 6 -12.213 -11.498
A 48 GLU 11 -12.100 -11.973
A 49 ARG 17 -14.387 -14.688
A 50 ARG 17 -14.315 -14.624
A 51 PRO 12 -13.883 -13.667
A 52 ILE 42 -16.469 -19.405
A 53 ARG 23 -12.077 -13.333
A 54 GLN 5 -8.480 -8.080
A 55 LEU 26 -11.424 -13.100
A 56 THR 1 -11.848 -10.600
A 57 PHE 18 -13.231 -13.779
A 58 GLN 0 -9.971 -8.824
A 59 ASP 17 -10.124 -10.915
A 60 LEU 29 -12.908 -14.759
A 61 HIS 5 -10.535 -9.898
A 62 LEU 13 -6.264 -7.038
A 63 HIS 2 -5.605 -5.190
A 64 ASP 0 -1.825 -1.616 <=B
A 65 LEU 12 -4.380 -5.257
A 66 ALA 21 -10.532 -11.736
A 67 GLN 4 -7.331 -6.948
A 68 ARG 9 -4.252 -4.798
A 69 HIS 21 -8.328 -9.785
A 70 GLY 16 -10.646 -11.262
A 71 LEU 28 -14.541 -16.089
A 72 GLU 12 -15.027 -14.679
A 73 SER 27 -17.672 -18.744
A 74 ALA 13 -15.968 -15.626
A 75 SER 18 -14.301 -14.726
A 76 ASP 11 -11.663 -11.586
A 77 HIS 0 -8.363 -7.401
A 78 HIS 8 -9.196 -9.058
A 79 GLY 20 -13.694 -14.419
A 80 ASN 12 -17.489 -16.857
A 81 PHE 27 -19.137 -20.041
A 82 SER 19 -20.520 -20.346
A 83 ILE 38 -20.555 -22.561
A 84 THR 16 -18.478 -18.193
A 85 MET 33 -16.179 -18.113
A 86 ARG 12 -11.331 -11.408
A 87 ASN 7 -10.895 -10.447
A 88 LEU 28 -13.256 -14.952
A 89 THR 6 -11.452 -10.825
A 90 LEU 5 -11.174 -10.464
A 91 LEU 9 -12.307 -11.927
A 92 ASP 31 -14.806 -16.668
A 93 SER 11 -16.058 -15.476
A 94 GLY 22 -17.084 -17.650
A 95 LEU 17 -20.337 -19.953
A 96 TYR 38 -22.796 -24.544
A 97 CYS 24 -23.903 -23.914
A 98 CYS 33 -23.592 -24.674
A 99 LEU 25 -17.974 -18.782
A 100 VAL 26 -16.258 -17.378
A 101 VAL 13 -12.686 -12.722
A 102 GLU 15 -8.238 -9.016
A 103 ILE 6 -6.565 -6.500
A 104 ARG 8 -1.212 -1.993 <=B
A 105 HIS 0 0.817 0.723 <=B
A 106 HIS 0 2.183 1.932 <=B
A 107 HIS 2 -0.863 -0.993 <=B
A 108 SER 8 -4.578 -4.972
A 109 GLU 8 -5.409 -5.707
A 110 HIS 14 -7.250 -8.026
A 111 ARG 14 -11.070 -11.407
A 112 VAL 18 -14.590 -14.982
A 113 HIS 19 -17.978 -18.096
A 114 GLY 28 -22.754 -23.357
A 115 ALA 14 -22.506 -21.528
A 116 MET 34 -22.576 -23.890
A 117 GLU 9 -21.601 -20.152
A 118 LEU 38 -20.067 -22.129
A 119 GLN 12 -16.824 -16.270
A 120 VAL 19 -14.230 -14.778
A 121 GLN 15 -8.508 -9.255
A 122 THR 9 -6.228 -6.547
A 123 GLY 5 -4.636 -4.678
A 124 LYS 0 -3.606 -3.192 <=B
A 125 ASP 5 -5.678 -5.600
A 126 ALA 18 -7.269 -8.503
A 127 PRO 16 -8.171 -9.071
A 128 SER 0 -6.779 -5.999
A 129 ASN 2 -9.552 -8.683
A 130 CYS 27 -14.456 -15.899
A 131 VAL 5 -14.967 -13.821

Identified 7 B-Cell epitope residues out of 131 total residues